Avanti Therapeutics, a privately held biopharmaceutical company, said it has incubated and launched a new bionanotechnology company for targeted drug delivery called Chikujee Therapeutics.
Chikujee Therapeutics hopes to commercialize nanomedicines using its proprietary, cell specific targeted drug delivery... - March 28, 2008
